Shares Intel (INTC.US) are up more than 5% before the opening of the Wall Street stock exchange following news that SoftBank will invest $2 billion in the US chip manufacturer. The Japanese conglomerate will buy shares at $23, which is a slight discount to the last closing price. This move is seen as a strong signal of confidence in Intel, which in recent years has lost ground in the race for dominance in artificial intelligence semiconductors to Nvidia and TSMC. For SoftBank, this is an expansion of its exposure to the US, alongside its existing holdings in Arm Holdings and its investment in the Stargate project. It should be noted that in recent days there have been reports that the Donald Trump administration is considering acquiring up to 10% of Intel's shares by converting grants awarded to it under the CHIPS Act into equity. At the time, however, this information pushed share prices down.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appSource: xStation
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
